Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 studyJonathan P. Piccini, Veronika Eder, Valeria Caso et al.|The Lancet|2022Cited by 310
Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve ReplacementOliver Hüsser, Stephan Ensminger, Buntaro Fujita et al.|JACC: Cardiovascular Interventions|2018Cited by 144
Light-Chain and Transthyretin Cardiac Amyloidosis in Severe Aortic Stenosis: Prevalence, Screening Possibilities, and OutcomeChristian Nitsche, Julia Mascherbauer, Jolanta M. Siller‐Matula et al.|European Journal of Heart Failure|2020Cited by 130
Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathyUlrike Esslinger, Eric Villard, Sophie Garnier et al.|PLoS ONE|2017Cited by 120
Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort studyPhilipp E. Bartko, Georg Goliasch, Gregor Heitzinger et al.|BMJ|2021Cited by 82